XLO
XLO insider trading: Xilio Therapeutics, Inc.
Every Form 4 purchase and sale by Xilio Therapeutics, Inc. officers, directors and 10% owners, newest filing first.
- 3
- Trades, last 365 days
- 1
- Purchases (code P)
- 2
- Sales (code S)
- Mar 30, 2026, 5:29 PM ET
- Latest filing
| Filed | Insider | Type | Shares | Price | Value | Traded | Owned after |
|---|---|---|---|---|---|---|---|
| Mar 30, 2026, 5:29 PM ET (open the Form 4 on EDGAR)Purchase (code P) | Shannon James SamuelDirector (current role) | Buy | Locked | Locked | Locked | Locked | Locked |
| Jan 5, 2026, 4:30 PM ET (open the Form 4 on EDGAR)Sale (code S) | Brennan Kevin M.SVP, FINANCE AND ACCOUNTING | Sell | Locked | Locked | Locked | Locked | Locked |
| Jan 5, 2026, 4:30 PM ET (open the Form 4 on EDGAR)Sale (code S) | Frankenfield Christopher JamesChief Financial Officer | Sell | Locked | Locked | Locked | Locked | Locked |
- Filed Mar 30, 2026, 5:29 PM ET (open the Form 4 on EDGAR)Purchase (code P)BuyShannon James SamuelDirector (current role)
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jan 5, 2026, 4:30 PM ET (open the Form 4 on EDGAR)Sale (code S)SellBrennan Kevin M.SVP, FINANCE AND ACCOUNTING
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jan 5, 2026, 4:30 PM ET (open the Form 4 on EDGAR)Sale (code S)SellFrankenfield Christopher JamesChief Financial Officer
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
Shares, price, value, trade date and holdings after the trade are locked on 3 rows here. Included with InsiderScanner ($9.99 a month) and Signal8 Pro.
Unlock with InsiderScanner